Pfizer

News

Person working at laptop with smartphone and coffee

Lawmakers seek answers on Pfizer, Lilly telehealth moves

US Senators are concerned that Pfizer and Eli Lilly's recent forays into direct-to-consumer distribution of medicines via telehealth platforms could violate federal anti-kickback laws.

News

Starboard spells out its concerns with Pfizer's direction

Activist investor Starboard Value has launched a broadside against Pfizer's leadership under chief executive Albert Bourla, claiming at least $20 billion in value – and possibly as much as

News

MSD preparing to take on Beyfortus with RSV antibody

New phase 2b/3 trial results with MSD's experimental respiratory syncytial virus (RSV) antibody clesrovimab have fired a shot across the bows of AstraZeneca and Sanofi, currently predicting

News

Pfizer sticks $1.5bn on Triana's molecular glue tech

Big pharma's interest in using protein degradation as a therapeutic strategy continues with a wide-ranging deal between Pfizer and US biotech Triana Biomedicines that could be worth $1.5 bi

News

Pfizer rounds out haemophilia portfolio with FDA approval

Pfizer’s anti-TFPI antibody marstacimab has been approved by the FDA to treat haemophilia, becoming the pharma group’s second new therapy for the blood disorder this year.

News

Starboard claims Pfizer 'threatened' former leaders

In another twist to the tale of Starboard Value's push for change at Pfizer, the activist investor has claimed former executives Ian Read and Frank D'Amelio were bullied into lending their

Lawmakers seek answers on Pfizer, Lilly telehealth moves

Starboard spells out its concerns with Pfizer's direction

MSD preparing to take on Beyfortus with RSV antibody

Pfizer sticks $1.5bn on Triana's molecular glue tech

Pfizer rounds out haemophilia portfolio with FDA approval

Starboard claims Pfizer 'threatened' former leaders

Lilly bags FDA okay for Wegovy pill rival orforglipron

Using AI-driven synthetic personas to take your insights fur...

Pfizer

Editor's Picks